Synonyms: | |
Status: | Approved (1955) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | P01BA02 |
UNII: | 4QWG6N8QKH |
InChI Key | XXSMGPRMXLTPCZ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C18H26ClN3O |
Molecular Weight | 335.88 |
AlogP | 3.78 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 9.0 |
Polar Surface Area | 48.39 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 23.0 |
Primary Target | |
---|---|
TLR7 | |
TLR9 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Toll-like and Il-1 receptors
|
- | 800-8600 | - | - | - | |
Unclassified protein
|
- | - | - | 92300 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Osteoarthritis | 3 | D010003 | ClinicalTrials |
Coronavirus Infections | 3 | D018352 | ClinicalTrials |
Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
Antiphospholipid Syndrome | 3 | D016736 | ClinicalTrials |
Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
Pregnancy | 3 | D011247 | ClinicalTrials |
Lupus Erythematosus, Cutaneous | 3 | D008178 | ClinicalTrials |
Graft vs Host Disease | 3 | D006086 | ClinicalTrials |
Sjogren's Syndrome | 3 | D012859 | ClinicalTrials |
Pneumonia | 3 | D011014 | ClinicalTrials |
Sarcoidosis, Pulmonary | 3 | D017565 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Respiratory Insufficiency | 3 | D012131 | ClinicalTrials |
Abortion, Habitual | 3 | D000026 | ClinicalTrials |
Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Thrombocytopenia | 3 | D013921 | ClinicalTrials |
Infections | 3 | D007239 | ClinicalTrials |
Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
Pneumonia, Pneumocystis | 3 | D011020 | ClinicalTrials |
Pneumonia, Viral | 3 | D011024 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Crohn Disease | 2 | D003424 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Leukemia | 2 | D007938 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
Osteoarthritis, Knee | 2 | D020370 | ClinicalTrials |
Lichen Planus | 2 | D008010 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Porphyria Cutanea Tarda | 2 | D017119 | ClinicalTrials |
Zellweger Syndrome | 2 | D015211 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
Adenocarcinoma | 1 | D000230 | ClinicalTrials |
Hidradenitis Suppurativa | 1 | D017497 | ClinicalTrials |
Hepatitis C, Chronic | 1 | D019698 | ClinicalTrials |
Hepatitis C | 1 | D006526 | ClinicalTrials |
Insulin Resistance | 1 | D007333 | ClinicalTrials |
Osteosarcoma | 1 | D012516 | ClinicalTrials |
Lymphangioleiomyomatosis | 1 | D018192 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
Glioma | 1 | D005910 | ClinicalTrials |
Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Retinitis Pigmentosa | 1 | D012174 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
Prostatic Neoplasms | 0 | D011471 | ClinicalTrials |
Lung Diseases, Interstitial | 0 | D017563 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 118-42-3 |
ChEBI | 5801 |
ChEMBL | CHEMBL1535 |
DrugBank | DB01611 |
DrugCentral | 1395 |
EPA CompTox | DTXSID8023135 |
FDA SRS | 4QWG6N8QKH |
Human Metabolome Database | HMDB0015549 |
Guide to Pharmacology | 7198 |
KEGG | C07043 |
PharmGKB | PA164777036 |
PubChem | 3652 |
SureChEMBL | SCHEMBL8170 |